Apellis is a global biopharmaceutical company that leverages courageous science, creativity, and compassion to develop life-changing therapies.

Leaders in Complement, at the forefront of targeted C3 therapies, we aim to develop transformative therapies for debilitating diseases driven by excessive activation of the complement cascade, including hematology, ophthalmology, nephrology, and neurology.

Contact Information:

For all general inquiries, please contact info@apellis.com

For all medical inquiries, please contact medinfo@apellis.com

 

Important External Links:

VISIT APELLIS MEDICAL HUB

LEARN MORE ABOUT GEOGRAPHIC ATROPHY